144 related articles for article (PubMed ID: 37574520)
1. Soluble TREM-1 plasma concentration predicts poor outcome in COVID-19 patients.
Gibot S; Lafon T; Jacquin L; Lefevre B; Kimmoun A; Guillaumot A; Losser MR; Douplat M; Argaud L; De Ciancio G; Jolly L; Touly N; Derive M; Malaplate C; Luc A; Baumann C; François B
Intensive Care Med Exp; 2023 Aug; 11(1):51. PubMed ID: 37574520
[TBL] [Abstract][Full Text] [Related]
2. Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19.
de Nooijer AH; Grondman I; Lambden S; Kooistra EJ; Janssen NAF; Kox M; Pickkers P; Joosten LAB; van de Veerdonk FL; Derive M; Gibot S; Netea MG;
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34195785
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of triggering receptor expressed on myeloid cells-1 and C-reactive protein for patients with lung infiltrates: an observational study.
Porfyridis I; Plachouras D; Karagianni V; Kotanidou A; Papiris SA; Giamarellou H; Giamarellos-Bourboulis EJ
BMC Infect Dis; 2010 Sep; 10():286. PubMed ID: 20920231
[TBL] [Abstract][Full Text] [Related]
4. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study.
Su L; Han B; Liu C; Liang L; Jiang Z; Deng J; Yan P; Jia Y; Feng D; Xie L
BMC Infect Dis; 2012 Jul; 12():157. PubMed ID: 22809118
[TBL] [Abstract][Full Text] [Related]
5. [Expression of triggering receptors expressed by myeloid cells-1 in macrophages stimulated by Porphyromonas gingivalis-lipopolysaccharide].
Yang Y; Chen SS; Xu CM; Wu YF; Zhao L
Hua Xi Kou Qiang Yi Xue Za Zhi; 2018 Oct; 36(5):475-481. PubMed ID: 30465338
[TBL] [Abstract][Full Text] [Related]
6. Differential pattern of cell-surface and soluble TREM-1 between sepsis and SIRS.
Oku R; Oda S; Nakada TA; Sadahiro T; Nakamura M; Hirayama Y; Abe R; Tateishi Y; Ito M; Iseki T; Hirasawa H
Cytokine; 2013 Jan; 61(1):112-7. PubMed ID: 23046618
[TBL] [Abstract][Full Text] [Related]
7. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis.
Gibot S; Cravoisy A; Kolopp-Sarda MN; Béné MC; Faure G; Bollaert PE; Levy B
Crit Care Med; 2005 Apr; 33(4):792-6. PubMed ID: 15818107
[TBL] [Abstract][Full Text] [Related]
8. Value of sTREM-1, procalcitonin and CRP as laboratory parameters for postmortem diagnosis of sepsis.
Palmiere C; Bardy D; Mangin P; Augsburger M
J Infect; 2013 Dec; 67(6):545-55. PubMed ID: 24012914
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support: the ESSENTIAL randomised, double-blind trial.
François B; Lambden S; Garaud JJ; Derive M; Grouin JM; Asfar P; Darreau C; Mira JP; Quenot JP; Lemarié J; Mercier E; Lacherade JC; Vinsonneau C; Fivez T; Helms J; Badie J; Levy M; Cuvier V; Salcedo-Magguilli M; Laszlo-Pouvreau AL; Laterre PF; Gibot S;
EClinicalMedicine; 2023 Jun; 60():102013. PubMed ID: 37350989
[TBL] [Abstract][Full Text] [Related]
10. sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity.
da Silva-Neto PV; de Carvalho JCS; Pimentel VE; Pérez MM; Toro DM; Fraga-Silva TFC; Fuzo CA; Oliveira CNS; Rodrigues LC; Argolo JGM; Carmona-Garcia I; Neto NT; Souza COS; Fernandes TM; Bastos VAF; Degiovani AM; Constant LF; Ostini FM; Feitosa MR; Parra RS; Vilar FC; Gaspar GG; da Rocha JJR; Feres O; Frantz FG; Gerlach RF; Maruyama SR; Russo EMS; Viana AL; Fernandes APM; Santos IKFM; Bonato VLD; Boechat AL; Malheiro A; Sadikot RT; Dias-Baruffi M; Cardoso CRB; Faccioli LH; Sorgi CA; On Behalf Of The Imunocovid Study Group
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960790
[TBL] [Abstract][Full Text] [Related]
11. Elevated plasma level of soluble triggering receptor expressed on myeloid cells-1 is associated with inflammation activity and is a potential biomarker of thrombosis in primary antiphospholipid syndrome.
Edel Y; Kliminski V; Pokroy-Shapira E; Oren S; Dortort Lazar A; Pri-Paz Basson Y; Egbaria M; Molad Y
Arthritis Res Ther; 2019 Jan; 21(1):10. PubMed ID: 30616644
[TBL] [Abstract][Full Text] [Related]
12. Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis.
Charles PE; Noel R; Massin F; Guy J; Bollaert PE; Quenot JP; Gibot S
BMC Infect Dis; 2016 Oct; 16(1):559. PubMed ID: 27729010
[TBL] [Abstract][Full Text] [Related]
13. Serum soluble triggering receptor expressed on myeloid cells-1 in acute respiratory distress syndrome: a prospective observational cohort study.
Lin MT; Wei YF; Ku SC; Lin CA; Ho CC; Yu CJ
J Formos Med Assoc; 2010 Nov; 109(11):800-9. PubMed ID: 21126652
[TBL] [Abstract][Full Text] [Related]
14. Measurement of plasma sTREM-1 in patients with severe sepsis receiving early goal-directed therapy and evaluation of its usefulness.
Jeong SJ; Song YG; Kim CO; Kim HW; Ku NS; Han SH; Choi JY; Kim JM
Shock; 2012 Jun; 37(6):574-8. PubMed ID: 22395243
[TBL] [Abstract][Full Text] [Related]
15. Soluble triggering receptor expressed on myeloid cells-1 is a marker of organ injuries in cardiogenic shock: results from the CardShock Study.
Kimmoun A; Duarte K; Harjola VP; Tarvasmäki T; Levy B; Mebazaa A; Gibot S;
Clin Res Cardiol; 2022 Jun; 111(6):604-613. PubMed ID: 33677708
[TBL] [Abstract][Full Text] [Related]
16. Soluble triggering receptor expressed on myeloid cells-1 is an early marker of infection in the surgical intensive care unit.
Rivera-Chavez FA; Minei JP
Surg Infect (Larchmt); 2009 Oct; 10(5):435-9. PubMed ID: 19792836
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU.
Anand NJ; Zuick S; Klesney-Tait J; Kollef MH
Chest; 2009 Mar; 135(3):641-647. PubMed ID: 18849395
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
19. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock.
Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL
J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104
[TBL] [Abstract][Full Text] [Related]
20. Can sTREM-1 predict septic shock & death in late-onset neonatal sepsis? A pilot study.
Arízaga-Ballesteros V; Alcorta-García MR; Lázaro-Martínez LC; Amézquita-Gómez JM; Alanís-Cajero JM; Villela L; Castorena-Torres F; Lara-Díaz VJ
Int J Infect Dis; 2015 Jan; 30():27-32. PubMed ID: 25461656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
